Study S001811

Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01499108
Acronym: Liratime
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 32
Start: 2012-08
Primary completion: 2013-07
Lead sponsor: Peter Rossing
Conditions: Type 2 Diabetes
Interventions: DRUG:liraglutide
Results posted: FALSE

Registered primary outcomes

Change in ambulatory blood pressure [50 days]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0011931	Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes. von Scholten BJ, Journal of diabetes and its complications	2015	Other trial	PMID 25935863 DOI	cites ClinicalTrials.gov:NCT01499108; registry reference DERIVED:25935863